Rheumatology - Alan J. Silman, Josef S. Smolen, Marc C. Hochberg | Consegna Gratis
In omaggio il libro "L'evoluzione a fumetti" se spendi più di 50 €


titolo Rheumatology
autori , , , ,
editore Mosby
formato Libro
pagine 1976
pubblicazione 2014
ISBN 9780323091381
18app Carta del docente Acquistabile con bonus 18app o Carta del docente
357,00 303,40 (-53.6€)
Spese di spedizione gratis
Stay current in the ever-changing discipline of rheumatology with clear, reliable guidance from Hochberg's Rheumatology, one of the most respected and trusted sources in the field. Designed to meet the needs of the practicing clinician, this medical reference book provides extensive, authoritative coverage of rheumatic diseases from basic scientific principles to practical points of clinical management in a lucid, logical, user-friendly manner.

Indice testuale

Section 1: The Scientific Basis of Rheumatic Disease 1. Epidemiologic concepts and the classification of rheumatic and musculoskeletal conditions 2. Principles of clinical outcome assessment 3. Principles of health economics and application to rheumatic disorders 4. The synovium 5. The articular cartilage 6. Bone structure and function 7. Tendons and ligaments 8. Connective tissue responses to mechanical stresses 9. Biomechanics of peripheral joints 10. Biomechanics of the spine 11. Principles of genetic epidemiology 12. Principles and techniques in molecular biology 13. Cytokines 14. Signal transduction in immune cells 15. The principles of adaptive immunity 16. Principles of innate immunity 17. Systems biology 18. Epigenetics in Rheumatology 19. The microbiome in rheumatic diseases 20. Tissue destruction and repair 21. Principles of tissue engineering and cell- and gene-based therapy 22. Osteoimmunology 23. Inflammation and its mediators 24. Scientific basis of pain 25. Effects of the neuroendocrine system on development and function of the immune system 26. Interpreting the medical literature for the rheumatologist: study design and levels of evidence 27. Ethics in clinical trials Section 2: Clinical Basis of Rheumatic Disease 28. History and physical examination 29. Pattern recognition in arthritis 30. Role of laboratory tests in rheumatic disorders 31. Synovial fluid analysis 32. Minimally invasive procedures 33. Skin in rheumatic disease 34. The eye in rheumatic disease 35. The heart in rheumatic disease 36. The lung in rheumatic disease 37. Gastrointestinal tract and rheumatic disease 38. The kidney and rheumatic disease 39. The nervous system in rheumatic disease Section 3: Evaluation: Imaging Techniques 40. Conventional radiography and computed tomography 41. Functional magnetic resonance imaging 42. Musculoskeletal ultrasound 43. Bone scintigraphy and positron emission tomography 44. Dual x-ray absorptiometry and measurement of bone 45. Use of imaging as an outcome measure in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis in clinical trials Section 4: Principles of Management 46. Arthritis patient education, health promotion, and team approaches to management 47. Principles of rehabilitation: physical and occupational therapy 48a. Complementary and alternative medicine 48b. Placebos, Caring and Healing in Rheumatology 49. Drug Development 50. Non-pharmacologic pain management 51. Pharmacogenomics in rheumatology 52. Principles of opioid treatment of chronic musculoskeletal pain 53. Non-steroidal anti-inflammatory drugs 54. Systemic glucocorticoids in rheumatology 55. Nonimmunosuppresive disease-modifying antirheumatic drugs 56. Methotrexate 57. Leflunomide 58. Immunosuppressives: cyclosporine, cyclophosphamide, azathioprine, mycophenolate mofetil 59. T-cell costimulation and other directed therapies 60. B-Cell depletion 61. Cytokine neutralizers: interleukin-1 inhibitors 62. Interleukin-6 Inhibition 63. Tumor necrosis factor blocking therapies 64. Kinase inhibition: a new therapeutic principle in rheumatology 65. Emerging therapeutic targets: GM-CSF, IL-17and IL-23 66. Biosimilars in Rheumatology 67. Infections and biologic therapy in rheumatoid arthritis: an update on risk and prevention 68. Drugs and pregnancy 69. Aspiration and injection of joints and periarticular tissues and intralesional therapy 70. Perioperative care of patients with rheumatic disease Section 5: Regional and Widespread Pain 71. Neck pain 72. Lumbar spine disorders 73. The shoulder 74. The elbow 75. The wrist and hand 76. The hip 77. The knee 78. The ankle and foot 79. The temporomandibular joint 80. Fibromyalgia and related syndrome 81. Entrapment neuropathies and compartment syndromes 82. Complex regional pain syndrome (reflex sympathetic dystrophy) Section 6: Rheumatoid Arthritis and Other Synovial Disorders 83. Classification and epidemiology of rheumatoid arthritis 84. Preclinical features of rheumatoid arthritis 85. Clinical features of rheumatoid arthritis 86. Extra-articular features of rheumatoid arthritis and systemic involvement 87. Adult-onset Still's disease 88. Imaging of rheumatoid arthritis 89. The contribution of genetic factors to rheumatoid arthritis 90. Animal models of arthritis 91. Autoantibodies in rheumatoid arthritis 92. Cellular immunity in rheumatoid arthritis 93. Angiogenesis and vasculogenesis in rheumatoid arthritis 94. The rheumatoid joint: synovitis and tissue destruction 95. Evaluation and management of early inflammatory polyarthritis 96. Evaluation and outcomes of patients with rheumatoid arthritis 97. Management of rheumatoid arthritis: synovitis 98. Multidisciplinary approach to rheumatoid arthritis Section 7: Pediatric Rheumatology 99a. Evaluation of musculoskeletal complaints in children: clinical evaluation 99b. Evaluation of musculoskeletal complaints in children: non-inflammatory musculoskeletal disorders 100. Classification and epidemiology of juvenile idiopathic arthritis 101. Clinical Features of juvenile idiopathic arthritis 102. Etiology and pathogenesis of juvenile idiopathic arthritis 103. Management of juvenile idiopathic arthritis 104. The juvenile-onset spondyloarthropathies 105. Connective tissues diseases in children 106. Rehabilitation and psychosocial issues in juvenile idiopathic arthritis Section 8: Infection-Related Rheumatic Diseases 107. Infectious Arthritis I: bacterial arthritis 108. Infectious Arthritis II: mycobacterium, brucella, fungal, and parasitic arthritis 109. Lyme disease 110. Rheumatologic aspects of viral infections 111. Acute rheumatic fever 112. Reactive arthritis Section 9: Spondyloarthropathies 113. Classification and epidemiology of spondyloarthritis 114. Clinical features of axial spondylarthritis 115. Etiology, pathogenesis, and pathophysiology of ankylosing spondylitis 116. Genetics of axial spondyloarthritis 117. Imaging of spondyloarthritis 118. Management of ankylosing spondylitis/axial spondyloarthritis 119. Classification and epidemiology of psoriatic arthritis 120. Clinical features of psoriatic arthritis 121. Etiology and pathogenesis of psoriatic arthritis 122. Management of psoriatic arthritis 123. Enthesopathies Section 10: Connective Tissue Disorders 124. Epidemiology and classification of systemic lupus erythematosus 125. Preclinical features of lupus 126. Clinical features of systemic lupus erythematosus 127. Genetics of lupus 128. Immunopathology of systemic lupus erythematosus 129. Animal models of lupus 130. Autoantibodies in systemic lupus erythematosus 131. Pathogenesis of lupus 132. Drug-induced lupus 133. Assessing disease activity and outcome in systemic lupus erythematosus 134. Management of non-renal/non-central nervous system lupus 135. Treatment of neuropsychiatric lupus 136. Systemic lupus erythematosus: treatment-renal involvement 137. Systemic lupus erythematosus in the pregnant patient and neonatal lupus 138. Sjogren syndrome 139. Antiphospholipid syndrome: overview of pathogensis, diagnosis, and management 140. Classification and epidemiology of scleroderma 141. Assessing disease activity and outcome in systematic sclerosis (scleroderma) 142. Clinical features of systemic sclerosis 143. Etiology and pathogenesis of systemic sclerosis 144. Management of systemic sclerosis 145. Pulmonary management of systemic sclerosis 146. Raynaud's phenomonen 147. Localized scleroderma and scleroderma-like syndromes 148. Clinical features, classification, and epidemiology of inflammatory muscle disease 149. Inflammatory muscle disease-etiology and pathogenesis 150. Management of inflammatory muscle disease 151. Metabolic, drug-induced, and other non-inflammatory myopathies 152. Overlap syndromes Section 11: The Vasculitides 153. Classification and epidemiology of vasculitis 154. Biology and immunopathogenesis of vasculitis 155. Polyarteritis nodosa and Cogan's Syndrome 156. Polymyalgia rheumatica and giant cell arteritis 157. Antineutrophil cytoplasmic antibody-associated vasculitis 158. Takayasu's arteritis 159. Behcet's syndrome 160. Kawasaki disease 161. Henoch-Schonlein purpura/immunoglobulin-A vasculitis 162. Cutaneous vasculitis and panniculitis 163. Cryoglobulinemia 164. Primary angiitis of the central nervous system Section 12: Other Systemic Illnesses 165. Monogenic autoinflammatory diseases 166. Sarcoidosis 167. Relapsing polychondritis 168. Amyloidosis 169. Digital clubbing and hypertrophic osteoarthropathy 170. Miscellaneous arthropathies Section 13:

Ti potrebbe interessare anche

Inserire il codice per il download.

Inserire il codice per attivare il servizio.

Questo sito o gli strumenti terzi da questo utilizzati si avvalgono di cookie necessari al funzionamento ed utili alle finalità illustrate nella cookie policy.
Se vuoi saperne di più o negare il consenso a tutti o ad alcuni cookie, consulta la cookie policy.
Chiudendo questo avviso, navigando in questa pagina, cliccando su un link o proseguendo la navigazione in altra maniera, acconsenti all'uso dei cookie.